Colon Cancer Clinical Trials

A listing of Colon Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Tucson Arizona 85719

A clinical research study of CPI-444 and CPI-444 + atezolizumab

California

Los Angeles California 90095

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Los Angeles California 90095

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

Orange California 92868

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

San Diego California 92121

A clinical trial seeking patients for a research study for the treatment of Colon Cancer, Colon Adenomas or Colon Polyps

San Francisco California 94143

A clinical research study of CPI-444 and CPI-444 + atezolizumab

View More ▼

Santa Monica California 90404

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Stanford California 94305

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Colorado

Aurora Colorado 80045

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Connecticut

New Haven Connecticut 06510

A clinical research study of CPI-444 and CPI-444 + atezolizumab

New Haven Connecticut 06510

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

New Haven Connecticut

Patients are needed to participate in a clinical research study evaluating MGA271 plus Ipilimumab for the treatment of Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer

Delaware

Newark Delaware 19713

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

District of Columbia

Washington District of Columbia 20057

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study of Regorafenib to evaluate Colon Cancer

Florida

Additional Locations Florida

Patients are needed to participate in a clinical research study of Regorafenib to evaluate Colorectal Neoplasms, Adenocarcinoma of the Colon or Adenocarcinoma of the Rectum

Gainesville Florida 32610

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

UPDATED

Miami Florida 33136

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Miami Beach Florida 33140

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Tampa Florida 33612

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Georgia

Memorial University Medical Center
Savannah Georgia 31404

CALGB 80702: A Phase III trial of 6 versus 12 Treatments of Adjuvant FOLFOX plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer.

View More ▼

Atlanta Georgia 30322

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Savannah Georgia 31404

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Illinois

Chicago Illinois 60612

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Chicago Illinois 60637

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Decatur Illinois 62526

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Naperville Illinois 60540-7499

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Indiana

Goshen Indiana 46526

A clinical trial seeking patients for a research study for the treatment of Metastatic Colorectal Cancer, Colon Cancer or Rectal Cancer

Indianapolis Indiana 46202

A clinical research study of CPI-444 and CPI-444 + atezolizumab

South Bend Indiana 46628

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Iowa

Davenport Iowa 52804

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Iowa City Iowa 52242

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Waterloo Iowa 50702

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Kentucky

Louisville Kentucky 40202

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Louisiana

New Orleans Louisiana 70112

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Maine

Scarborough Maine 04074

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Maryland

Baltimore Maryland 21287

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Baltimore Maryland 21205

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Baltimore Maryland 21201

Patients are needed to participate in a clinical research study of MGA271 and Pembrolizumab to evaluate Melanoma, Head and Neck Cancer or Non Small Cell Lung Cancer, Refractory Cancer

Massachusetts

Boston Massachusetts 02215

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Boston Massachusetts 02114

A clinical trial to evaluate treatments using MGD007 for patients with Colorectal Carcinoma

Pittsfield Massachusetts 01201

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Michigan

Detroit Michigan 48201

A clinical research study of CPI-444 and CPI-444 + atezolizumab

UPDATED

Detroit Michigan 48201

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Lansing Michigan 48910

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Minnesota

St. Louis Park Minnesota 55416

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer

Missouri

St. Louis Missouri 63110

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Nebraska

Omaha Nebraska 68154

A clinical research study of CPI-444 and CPI-444 + atezolizumab

Omaha Nebraska 68106

A clinical trial to evaluate treatments using Regorafenib and Placebo for patients with Stage III (IIIB or IIIC) Colon Cancer